摘要
目前临床常用的糖尿病周围神经病变的筛查和诊断方法种类很多，包括各种不同的筛查工具、不同的临床评分量表、定量感觉检查和神经传导功能检查等。但由于不同的检查各自的侧重点不同，其实际诊断的效率差别较大，导致其无法得到早期诊断，进而延误治疗。近年来，SUDOSCAN作为一种新型的筛查工具，因其具有简便、无创和定量的优点已在国外临床大规模应用，其可以通过测定手部、足部电导率值进而早期诊断糖尿病周围神经病变，并可以通过计算得到的肾脏病变、心脏自主神经病变风险值继而评估糖尿病患者并发症的发生风险。
There are many clinical screening and diagnostic methods of diabetic peripheral neuropathy, including different screening tools and scores, quantitative sensory testing, nerve conduction studies, etc. However, due to different focus on different examination, the actual diagnostic efficiency varies differently from each other which leads to ignorance of early diagnosis and delayed treatment of diabetic neuropathy. In recent years, SUDOSCAN has been applied widely in clinical use abroad because it has been proved to be simple, non-invasive and quantitative as a new screening tool, thus leading to an early detection of diabetic peripheral neuropathy through measurement of hands and feet conductivity values. It can also assess the possible occurrence of diabetic complications by calculating the risk values of renal dysfunction and cardiac autonomic nervous disease.
出处
《国际内分泌代谢杂志》
2016年第5期331-333,共3页
International Journal of Endocrinology and Metabolism
